Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.
Demelo-Rodriguez P, Farfán-Sedano AI, Pedrajas JM, Llamas P, Sigüenza P, Jaras MJ, Quintana-Diaz M, Fernández-Capitán C, Bikdeli B, Jiménez D, Monreal M; RIETE-BLEEDING Investigators.
Demelo-Rodriguez P, et al. Among authors: jaras mj.
J Thromb Haemost. 2021 Aug;19(8):1981-1989. doi: 10.1111/jth.15400. Epub 2021 Jun 20.
J Thromb Haemost. 2021.
PMID: 34018658
Free PMC article.